Business Wire

Celltrion Pharm Signs Strategic Trilateral Agreement with Becton Dickinson and BD Korea to Accelerate Global PFS CMO Business

CHEONGJU, South Korea--(BUSINESS WIRE)--Celltrion Pharm (KOSDAQ: 068706), a South Korean biopharmaceutical firm, said on September 16 that it has inked a strategic trilateral agreement with a ...
Seeking Alpha

West Pharmaceutical Services, Inc. (WST) Discusses Integrated Prefillable Syringe Systems to Streamline Drug Development and Reduce Complexity Transcript

As drug development teams finalize molecule optimization, packing development begins. Often a time-consuming process of evaluating multiple components, suppliers and test results. For prefilled ...
Nasdaq

BD's (BDX) Latest PFS Launch to Boost Production Efficiencies

Becton, Dickinson and Company BDX, popularly known as BD, recently launched a next-generation glass prefillable syringe (PFS) — BD Effivax Glass Prefillable Syringe. The latest PFS has been designed ...
Nasdaq

FDA Approves Genentech’s Vabysmo Prefilled Syringe (PFS) for Three Leading Causes of Vision Loss

– Vabysmo PFS is the first and only syringe prefilled with an FDA-approved bispecific antibody to treat retinal conditions that can cause blindness – – Designed to simplify administration, Vabysmo PFS ...
Yahoo Finance

2 Day Pre-Filled Syringes Practical Course: Gain a Clear Overview of the Entire Processing Journey, from Component Selection and Design Considerations (ONLINE EVENT: May 11th ...

Dublin, April 14, 2026 (GLOBE NEWSWIRE)-- The "A Practical Overview of Pre-Filled Syringes (May 11th - May 12th, 2026)" training has been added to ResearchAndMarkets.com's offering. This course offers ...
Medscape

FDA Clears Ranibizumab Injection in a Prefilled Syringe

The US Food and Drug Administration (FDA) has approved ranibizumab injection (Lucentis, Genentech) in a prefilled syringe, the company has announced. Like the Lucentis 0.5 mg vial, the 0.5 mg ...
Monthly Prescribing Reference

Additional Strength of Lucentis Prefilled Syringe FDA-Approved

The 0.3mg PFS marks the first approved syringe with an anti-vascular endothelial growth factor (VEGF) to treat all forms of diabetic retinopathy with or without diabetic macular edema (DME). Genentech ...